Copenhagen, Denmark, November 3, 2025 — Novo Holdings, a leading life sciences investment firm, has announced the appointment of Helle Bach as Chief People Officer, effective November 1, 2025. In her new role, Helle will join the Executive Leadership Team, drive talent strategy and recruitment, and oversee human resources functions across Novo Holdings’ seven offices in Europe, North America, and Asia.
Helle brings to Novo Holdings more than 20 years of experience in the People function, most recently serving as Executive Vice President, Group HR at DSV, Denmark’s second-largest company by market capitalisation. Prior to this, she was Vice President, Corporate HR at Egmont International Holding. Over the course of her career, she has led global talent attraction strategies, implemented leadership development programs, and built integrated HR processes and policies that align organizational goals with culture across multiple geographies.
“Helle has excelled at building scalable and effective solutions in the People function, bringing a broad, international perspective, and a strong track record of developing human resources in global contexts,” said Kasper Sobfeldt Jahn, Chief Strategy Officer, Novo Holdings.
“She will be a very strong asset for our organisation as Novo Holdings continues to grow in size and complexity.”
“Novo Holdings is distinct in its long-term view and mission and its commitment to generate attractive returns for the Novo Nordisk Foundation,” said Helle Bach, Chief People Officer, Novo Holdings.
“I’m looking forward to further enhancing the people function within Novo Holdings as a leading investor supporting innovative companies across the globe.”
In her capacity as Chief People Officer, Helle will focus on strengthening Novo Holdings’ global talent ecosystem, fostering leadership excellence, and supporting a high-performance culture aligned with the company’s purpose-driven investment philosophy. Her appointment comes at a time when Novo Holdings continues to expand its international presence and portfolio, underscoring the growing importance of strategic people leadership across its global operations.
About Novo Holdings
Novo Holdings is a holding and investment company responsible for managing the assets and wealth of the Novo Nordisk Foundation, one of the world’s largest philanthropic enterprise foundations.
The company is the controlling shareholder of Novo Nordisk A/S and Novonesis A/S, and manages a diverse investment portfolio with a long-term return perspective. In addition to managing equities, bonds, real estate, infrastructure, and private equity assets, Novo Holdings is a world-leading life sciences investor. Through its Seeds, Venture, Growth, Principal, and Planetary Health Investments teams, the company invests in life science companies at all stages of development, driving innovation and sustainable impact worldwide.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
